These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8907070)

  • 1. Intravenous immunoglobulin in rheumatic disease.
    Klassen LW; Calabrese LH; Laxer RM
    Rheum Dis Clin North Am; 1996 Feb; 22(1):155-73. PubMed ID: 8907070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic complications of treatment of childhood acute immune thrombocytopenic purpura with intravenously administered immunoglobulin G.
    Kattamis AC; Shankar S; Cohen AR
    J Pediatr; 1997 Feb; 130(2):281-3. PubMed ID: 9042132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin and autoimmune thrombocytopenic purpura: 22 years on.
    Bierling P; Godeau B
    Vox Sang; 2004 Jan; 86(1):8-14. PubMed ID: 14984554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
    Ruggeri M; Castaman G; De Nardi G; Rodeghiero F
    Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin high-dose therapy: RBC-alloantibodies in commercial preparations and haemolytic anaemia: a case report.
    Kluge A; Dopfer R; Pfeiffer-Wolf I; Roelcke D
    Beitr Infusionsther Transfusionsmed; 1994; 32():474-5. PubMed ID: 9422126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin therapy for rheumatic diseases.
    Sany J
    Curr Opin Rheumatol; 1994 May; 6(3):305-10. PubMed ID: 8060767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of childhood immune thrombocytopenic purpura.
    Lilleyman JS
    Lancet; 1994 Oct; 344(8930):1155. PubMed ID: 7934509
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.
    Bierling P; Godeau B
    Hum Immunol; 2005 Apr; 66(4):387-94. PubMed ID: 15866702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral sinus thrombosis following IV immunoglobulin therapy of immune thrombocytopenia purpura.
    Al-Riyami AZ; Lee J; Connolly M; Shereck E
    Pediatr Blood Cancer; 2011 Jul; 57(1):157-9. PubMed ID: 21445949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous immunoglobulin administration in thrombocytopenias in adults (based on data from the foreign literature)].
    Sharygin SL
    Sov Med; 1991; (7):37-9. PubMed ID: 1948340
    [No Abstract]   [Full Text] [Related]  

  • 11. Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura.
    Mitterer M; Pescosta N; Vogetseder W; Mair M; Coser P
    Ann Hematol; 1993 Sep; 67(3):151-2. PubMed ID: 8373906
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of idiopathic thrombocytopenic purpura using a dose of immunoglobulin based on lean body mass.
    Woolfrey S; Dewar MS
    Ann Pharmacother; 1993 Apr; 27(4):510. PubMed ID: 8477131
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.
    Pacetti P; Garau D; Caramatti C; Mangoni L; Zamboni V; Canova N; Rizzoli V
    Curr Med Res Opin; 1997; 13(9):517-27. PubMed ID: 9169254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged remission of SLE-associated polyradiculoneuropathy after a single course of intravenous immunoglobulin.
    Lesprit P; Mouloud F; Bierling P; Schaeffer A; Cesaro P; Brun-Buisson C; Godeau B
    Scand J Rheumatol; 1996; 25(3):177-9. PubMed ID: 8668963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral infarctions after intravenous immunoglobulin therapy for ITP in a child.
    Lorenzana A; Armin S; Sharma A; Allarakhia I; Witkowski A
    Pediatr Neurol; 2014 Feb; 50(2):188-91. PubMed ID: 24262342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reality and clinical application of immunoglobulin preparations].
    Miyara T; Saito A
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):824-8. PubMed ID: 8753046
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal failure and intravenous immunoglobulin.
    Phillips AO
    Clin Nephrol; 1992 Apr; 37(4):217. PubMed ID: 1582064
    [No Abstract]   [Full Text] [Related]  

  • 19. [The indications for intravenous immunoglobulins in pediatric practice].
    Popescu V; Bleahu D
    Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects on the efficacy of high-dose intravenous immunoglobulins in patients with autoimmune thrombocytopenia.
    Mayer B; Depré F; Ringel F; Salama A
    Vox Sang; 2017 Jan; 112(1):64-69. PubMed ID: 28001314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.